Richard Law
Stock Analyst at Goldman Sachs
(0)
# 4434
Out of 5,331 analysts
59
Total ratings
38.46%
Success rate
-13.24%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
RCKT Rocket Pharmaceutica... | Maintains: Neutral | 29 15 | 8.01 | 87.27% | 2 | Mar 3, 2025 | |
CLDX Celldex Therapeutics | Maintains: Neutral | 42 36 | 20.73 | 73.66% | 2 | Mar 3, 2025 | |
MLTX MoonLake | Maintains: Buy | 82 73 | 42.34 | 72.41% | 3 | Feb 27, 2025 | |
MLYS Mineralys Therapeuti... | Maintains: Buy | 28 24 | 15.38 | 56.05% | 6 | Feb 13, 2025 | |
VRDN Viridian Therapeutic... | Maintains: Strong Buy | 25 31 | 13.64 | 127.27% | 2 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 24 | 5.62 | 327.05% | 4 | Apr 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 11 | 4.96 | 121.77% | 4 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 31 | 5.18 | 498.46% | 2 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 46 47 | 20.25 | 132.1% | 3 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 62 63 | 38.36 | 64.23% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 36 37 | 35.33 | 4.73% | 8 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 76 | 8.88 | 755.86% | 6 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 36 | n/a | n/a | 4 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 15 14 | 1.64 | 753.66% | 3 | May 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 61 | 7.69 | 693.24% | 4 | May 8, 2023 |